Kawasaki disease

Textbook of Pediatric Rheumatology

Volumn , Issue , 2005, Pages 521-538

  Sundel, Robert P ^a,b   Petty, Ross E ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33744486576     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-0246-8.50031-0     Document Type: Chapter

References (166)

1. Kawasaki T Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967, 16:178-222.
2. Itoga S, Yamagishi M Steroid treatment for mucocutaneous ocular syndrome in childhood. Chiryo (Japan) 1960, 42:1174-1179.
3. Shulman ST The first reported case of Kawasaki disease?. J Pediatr 1999, 135:532.
4. Matteson EL Notes on the history of eponymic idiopathic vasculitis: the diseases of Henoch and Schonlein, Wegener, Churg and Strauss, Horton, Takayasu, Behcet, and Kawasaki. Arthritis Care Res 2000, 13:237-245.
5. Centers for Disease Control and Prevention CDC revised diagnostic criteria for Kawasaki disease. MMWR Morb Mortal Wkly Rep 1990, 39:27-28.
6. Burns JC, Mason WH, Glode M, Shulman ST, et al. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr 1991, 118:680-686.
7. Benseler SM, McCrindle BW, Silverman ED, et al. Infections and Kawasaki disease: implications for coronary artery outcome. Arthritis Rheum 2003, 48(Suppl):S516.
8. Hsieh YC, Wu MH, Wang JK, et al. Clinical features of atypical Kawasaki disease. J Microbiol Immunol Infect 2002, 35:57-60.
9. Witt MT, Minich LL, Bohnsack JF, Young PC Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteria. Pediatrics 1999, 104:e10.
10. Rosenfeld EA, Corydon KE, Shulman ST Kawasaki disease in infants less than one year of age. J Pediatr 1995, 126:524-529.
11. Holman RC, Curns AT, Belay ED, et al. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatr 2003, 112:495-501.
12. Chang RK The incidence of Kawasaki disease in the United States did not increase between 1988 and 1997. Pediatrics 2003, 111:1124-1125.
13. Stockheim JA, Innocentini N, Shulman ST Kawasaki disease in older children and adolescents. J Pediatr 2000, 137:250-252.
14. Tomiyama J, Hasegawa Y, Kumagai Y, et al. Acute febrile mucocutaneous lymph node syndrome (Kawasaki disease) in adults: case report and review of the literature. Jpn J Med 1991, 30:285-289.
15. Newburger JW, Taubert KA, Shulman SDT, et al. Summary and abstracts of the Seventh International Kawasaki Disease Symposium, December 4-7, 2001. Hakone, Japan. Pediatr Res 2003, 53:153-157.
16. Yanagawa H, Nakamura Y, Yashiro M, et al. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics 1998, 102:E65.
17. Yanagawa H, Nakamura Y, Yashiro M, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001, 107:E33.
18. Shulman ST, McAuley JB, Pachman LM, et al. Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population. Am J Dis Child 1987, 141:420-425.
19. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 2002, 360:1197-1202.
20. Yanagawa H, Yashiro M, Nakamura Y, et al. Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992. Pediatrics 1995, 95:449-473.
21. Royle JA, Williams K, Elliott E, et al. Kawasaki disease in Australia, 1993-95. Arch Dis Child 1998, 78:33-39.
22. Bell DM, Morens DM, Holman RC, et al. Kawasaki syndrome in the United States 1976 to 1980. Am J Dis Child 1983, 137:211-214.
23. Yanagawa H, Nakamura Y, Ojima T, et al. Changes in epidemic patterns of Kawasaki disease in Japan. Pediatr Infect Dis J 1999, 18:64-66.
24. Fujita Y, Nakamura Y, Sakata K, et al. Kawasaki disease in families. Pediatrics 1989, 84:666-669.
25. Hewitt M, Smith LJ, Joffe HS, Chambers TL Kawasaki disease in siblings. Arch Dis Child 1989, 64:389-398.
26. Newburger J Treatment of Kawasaki disease: corticosteroids revisited. J Pediatr 1999, 135:411-413.
27. Rowley AH, Wolinsky SM, Relman DA, et al. Search for highly conserved viral and bacterial nucleic acid sequences corresponding to an etiologic agent of Kawasaki disease. Pediatr Res 1994, 36:567-571.
28. Rowley AH The etiology of Kawasaki disease: superantigen or conventional antigen?. Pediatr Infect Dis J 1999, 18:69-70.
29. Leung DY, Giorno RC, Kazemi LV, et al. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. J Immunol 1995, 155:5018-5021.
30. Yamashiro Y, Nagata S, Oguchi S, Shimizu T Selective increase of VB2+ T-cells in the small intestinal mucosa in Kawasaki disease. Pediatr Res 1996, 39:264-266.
31. Brogan PA, Shah V, Klein N, Dillon MJ V beta-restricted T-cell adherence to endothelial cells: A mechanism for superantigen-dependent vascular injury. Arthritis Rheum 2004, 50:589-597.
32. Nomura Y, Yoshinaga M, Masuda K, et al. Maternal antibody against toxic shock syndrome toxin-1 may protect infants younger than 6 months of age from developing Kawasaki syndrome. J Infect Dis 2002, 185:1677-1680.
33. Duong TT, Silverman ED, Bissessar MV, Yeung RS Superantigenic activity is responsible for induction of coronary arteritis in mice: an animal model of Kawasaki disease. Int Immunol 2003, 15:79-89.
34. Hsu YH, Wang YH, Hsu WY, Lee YP Kawasaki disease characterized by erythema and induration at the Bacillus Calmette-Guérin and purified protein derivative inoculation sites. Pediatr Infect Dis J 1987, 6:576-578.
35. Bertotto A, Spinozzi F, Vagliasindi C, et al. Tuberculin skin test reactivity in Kawasaki disease. Pediatr Res 1997, 41:560-562.
36. Yokota S, Tsubaki K, Kuriyama T, et al. Presence in Kawasaki disease of antibodies to mycobacterial heat-shock protein HSP65 and autoantibodies to epitopes of human HSP65 cognate antigen. Clin Immunol Immunopathol 1993, 67:163-170.
37. Rowley AH, Shulman ST, Spike BT, et al. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol 2001, 166:1334-1343.
38. Kikuta H, Sakiyama Y, Matsumoto S, et al. Detection of Epstein-Barr virus DNA in cardiac and aortic tissues from chronic, active Epstein-Barr virus infection associated with Kawasaki disease-like coronary artery aneurysms. J Pediatr 1993, 123:90-92.
39. Matsuno M, Utagawa E, Sugiura A Association of rotavirus infections with Kawasaki syndrome. J Infect Dis 1983, 148:177.
40. Okano M, Thiele GM, Sakiyama Y, et al. Adenovirus infection in patients with Kawasaki disease. J Med Virol 1990, 32:53-57.
41. Holm JM, Hansen LK, Oxhoj H Kawasaki disease associated with parvovirus B19 infection. Eur J Pediatr 1995, 154:633-634.
42. Burns JC, Geha RS, Schneeberger EE, et al. Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease. Nature 1986, 323:814-816.
43. Normann E, Naas J, Gnarpe J, et al. Demonstration of Chlamydia pneumoniae in cardiovascular tissues from children with Kawasaki disease. Pediatr Infect Dis J 1999, 18:72-73.
44. Akiyama T, Yashiro K Probable role of Streptococcus pyogenes in Kawasaki disease. Eur J Pediatr 1993, 152:82-92.
45. Nonoyama S Immunological abnormalities and endothelial cell injury in Kawasaki disease. Acta Paediatr Jpn 1991, 33:752-755.
46. Savage CO, Tizard J, Jayne D, et al. Antineutrophil cytoplasm antibodies in Kawasaki disease. Arch Dis Child 1989, 64:360-363.
47. Furukawa S, Matsubara T, Okumura K, Yabuta K Decreased expression of CD23 on peripheral blood macrophages/monocytes during acute Kawasaki disease with coronary artery lesions. Int Arch Allergy Immunol 1993, 102:335-339.
48. Lin CY, Lin CC, Hwang B, Chiang B Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr 1992, 121:924-926.
49. Yasukawa K, Terai M, Shulman ST, et al. Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. Circulation 2002, 105:766-769.
50. Kuijpers T, Wiegman A, van Lier RA, et al. Kawasaki disease: a maturational defect in immune responsiveness. J Infect Dis 1999, 180:1869-1877.
51. Yanagawa H, Yashiro M, Nakamura Y, et al. Nationwide surveillance of Kawasaki disease in Japan, 1984 to 1993. Pediatr Infect Dis J 1995, 14:69-71.
52. Harada F, Sada M, Kamiya T, et al. Genetic analysis of Kawasaki syndrome. Am J Hum Genet 1986, 39:537-539.
53. Uehara R, Yashiro M, Nakamura Y, Yanagawa H Kawasaki disease in parents and children. Acta Paediatr 2003, 92:694-697.
54. Huang Y, Lee YJ, Chen MR, et al. Polymorphism of transmembrane region of MICA gene and Kawasaki disease. Exp Clin Immunogenet 2000, 17:130-137.
55. Barron KS, Silverman ED, Gonzales JC, et al. Major histocompatibility complex class II alleles in Kawasaki syndrome-lack of consistent correlation with disease or cardiac involvement. J Rheumatol 1992, 19:1790-1793.
56. Quasney MW, Bronstein DE, Cantor RM, et al. Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki disease. Pediatr Res 2001, 49:686-690.
57. Ahn SY, Jang GC, Shin JS, et al. Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea. Yonsei Med J 2003, 44:1021-1026.
58. Nishimura S, Zaitsu M, Hara M, et al. A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease. J Pediatr 2003, 143:357-362.
59. Takeuchi K, Yamamoto K, Kataoka S, et al. High incidence of angiotensin I converting enzyme genotype II in Kawasaki disease patients with coronary aneurysm. Eur J Pediatr 1997, 156:266-268.
60. Barron KS Kawasaki disease: etiology, pathogenesis, and treatment. Cleve Clin J Med 2002, 69(Suppl 2):SII69-SII78.
61. Smith LB, Newburger JW, Burns JC Kawasaki syndrome and the eye. Pediatr Infect Dis J 1989, 8:116-118.
62. Ammerman SD, Rao MS, Shope TC, Ragsdale CG Diagnostic uncertainty in atypical Kawasaki disease, and a new finding: exudative conjunctivitis. Pediatr Infect Dis 1985, 4:210-211.
63. Ryan EH, Walton DS Conjunctival scarring in Kawasaki disease: a new finding?. J Pediatr Ophthalmol Strabismus 1983, 20:106-108.
64. Jacob JL, Polomeno RC, Chad Z, Lapointe N Ocular manifestations of Kawasaki disease (mucocutaneous lymph node syndrome). Can J Ophthalmol 1982, 17:199-202.
65. Eberhard BA, Sundel RP, Newburger JW, et al. Psoriatic eruption in Kawasaki disease. J Pediatr 2000, 137:578-580.
66. Tashiro N, Matsubara T, Uchida M, et al. Ultrasonographic evaluation of cervical lymph nodes in Kawasaki disease. Pediatrics 2002, 109:E77-E87.
67. Levy M, Koren G Atypical Kawasaki disease: analysis of clinical presentation and diagnostic clues. Pediatr Infect Dis J 1990, 9:122-126.
68. Fukushige J, Takahashi N, Ueda Y, Ueda K Incidence and clinical features of incomplete Kawasaki disease. Acta Paediatr 1994, 83:1057-1060.
69. Joffe A, Kabani A, Jadavji T Atypical and complicated Kawasaki disease in infants. Do we need criteria? West J Med 1995, 162:322-327.
70. Yanagawa H, Tuohong Z, Oki I, et al. Effects of gamma-globulin on the cardiac sequelae of Kawasaki disease. Pediatr Cardiol 1999, 20:248-251.
71. Burns JC, Capparelli EV, Brown JA, et al. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 1998, 17:1144-1148.
72. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996, 94:1379-1385.
73. Kato H, Ichinose E, Kawasaki T Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr 1986, 108:923-927.
74. Kato H, Ichinose E, Yoshioka F, et al. Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am J Cardiol 1982, 49:1758-1766.
75. Iemura M, Ishii M, Sugimura T, et al. Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart 2000, 83:307-311.
76. Matsuura H, Ishikita T, Yamamoto S, et al. Gallium-67 myocardial imaging for the detection of myocarditis in the acute phase of Kawasaki disease (mucocutaneous lymph node syndrome): the usefulness of single photon emission computed tomography. Br Heart J 1987, 58:385-392.
77. Newburger JW, Sanders SP, Burns JC, et al. Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin. Circulation 1989, 79:1237-1246.
78. Moran A, Newburger JW, Sanders SP, et al. Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma globulin. Am Heart J 2000, 139:217-223.
79. Mele T, Evans M Intestinal obstruction as a complication of Kawasaki disease. J Pediatr Surg 1996, 31:985-986.
80. Zulian F, Falcini F, Zancan L, et al. Acute surgical abdomen as presenting manifestation of Kawasaki disease. J Pediatr 2003, 142:731-735.
81. Dengler LD, Capparelli EV, Bastian JF, et al. Cerebrospinal fluid profile in patients with acute Kawasaki disease. Pediatr Infect Dis J 1998, 17:478-481.
82. Tabarki B, Mahdhaoui A, Selmi H, et al. Kawasaki disease with predominant central nervous system involvement. Pediatr Neurol 2001, 25:239-241.
83. Larralde M, Santos-Munoz A, Rutiman R Kawasaki disease with facial nerve paralysis. Pediatr Dermatol 2003, 20:511-513.
84. Kumagai N, Ohno S Kawasaki disease. Ocular Immunity and Infection 1996, 391-396. Mosby, St. Louis. J.S. Pepose, G.N. Holland, K.R. Wilhelmus (Eds.).
85. Blatt AN, Vogler L, Tychsen L Incomplete presentations in a series of 37 children with Kawasaki disease: the role of the pediatric ophthalmologist. J Pediatr Ophthalmol Strabismus 1996, 33:114-119.
86. Melish ME Kawasaki syndrome: a 1986 perspective. Rheum Dis Clin North Am 1987, 13:7-17.
87. Sundel RP, Cleveland SS, Beiser AS, et al. Audiologic profiles of children with Kawasaki disease. Am J Otol 1992, 13:512-515.
88. Suddleson EA, Reid B, Woolley MM, Takahashi M Hydrops of the gallbladder associated with Kawasaki syndrome. J Pediatr Surg 1987, 22:956-959.
89. Waring NP, Ortenberg J, Galen WK, et al. Priapism in Kawasaki disease. JAMA 1989, 261:1730-1731.
90. Ferriero DM, Wolfsdorf JI Hemolytic uremic syndrome associated with Kawasaki disease. Pediatrics 1981, 68:405-406.
91. Salcedo JR, Greenberg L, Kapur S Renal histology of mucocutaneous lymph node syndrome (Kawasaki disease). Clin Nephrol 1988, 29:47-51.
92. Lande MB, Gleeson JG, Sundel RP Kawasaki disease and acute renal failure. Pediatr Nephrol 1993, 7:593.
93. Yanagihara R, Todd JK Acute febrile mucocutaneous lymph node syndrome. Am J Dis Child 1980, 134:603-610.
94. Naoe S, Takahashi K, Masuda H, Tanaka N Kawasaki disease. With particular emphasis on arterial lesions. Acta Pathol Jpn 1991, 41:785-797.
95. Fujiwara H, Hamashima Y Pathology of the heart in Kawasaki disease. Pediatr 1978, 61:100-107.
96. Rowley AH, Eckerley CA, Jack HM, et al. IgA Plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol 1997, 159:5946-5955.
97. Jennette JC Implications for pathogenesis of patterns of injury in small- and medium-sized vessel vasculitis. Cleve Clin J Med 2002, 69(Suppl 2):SII33-SII38.
98. Leung DY, Cotran RS, Kurt-Jones E, et al. Endothelial activation in the pathogenesis of Kawasaki disease. Trans Assoc Am Physicians 1989, 102:131-138.
99. Yonesaka S, Nakada T, Sunagawa Y, et al. Endomyocardial biopsy in children with Kawasaki disease. Acta Paediatr Jpn 1989, 31:706-711.
100. Fujiwara H, Hamashima Y Pathology of the heart in Kawasaki disease. Pediatrics 1978, 61:100-107.
101. Suzuki A, Kamiya T, Kuwahara N, et al. Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr Cardiol 1986, 7:3-9.
102. Hara T, Mizuno Y, Ueda K, et al. Neutropenia in Kawasaki disease. Eur J Pediatr 1989, 148:580.
103. Rowe PC, Quinlan A, Luke BK Value of degenerative change in neutrophils as a diagnostic test for Kawasaki syndrome. J Pediatr 1991, 119:370-374.
104. Salo E, Pesonen E, Viikari J Serum cholesterol levels during and after Kawasaki disease. J Pediatr 1991, 119:557-561.
105. Soppi E, Salo E, Pelkonen P Antibodies against neutrophil cytoplasmic components in Kawasaki disease. Acta Path Microbiol Immunol Scand 1992, 100:269-272.
106. Grunebaum E, Blank M, Cohen S, et al. The role of anti-endothelial cell anti-bodies in Kawasaki disease-in vitro and in vivo studies. Clin Exp Immunol 2002, 130:233-240.
107. Guzman J, Fung M, Petty RE Diagnostic value of anti-neutrophil cytoplasmic and anti-endothelial cell antibodies in early Kawasaki disease. J Pediatr 1994, 124:917-920.
108. Irazuzta JE, Elbl F, Rees AR Factor VIII related antigen (von Willebrand's factor) in Kawasaki disease. Clin Pediatr (Phila) 1990, 29:347-348.
109. Laxer RM, Schaffer FM, Myones BL, et al. Lymphocyte abnormalities and complement activation in Kawasaki disease. Prog Clin Biol Res 1987, 250:175-184.
110. American Academy of Pediatrics Kawasaki syndrome. Red Book: 2003 Report of the Committee on Infectious Diseases 2003, 392-395. American Academy of Pediatrics, Elk Grove Village, II. L.K. Pickering (Ed.).
111. Ishihara H, Watanabe S, Izumida N, et al. Detection of coronary arterial lesions by two dimensional echocardiography in patients with Kawasaki disease. Bull Tokyo Med Dent Univ 1984, 31:139-143.
112. Report of the Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease 1984, Ministry of Health and Welfare, Tokyo, Japan.
113. Oberhoffer R, Lang D, Feilen K The diameter of coronary arteries in infants and children without heart disease. Eur J Pediatr 1989, 148:389-392.
114. de Zorzi A, Colan SD, Gauvreau K, et al. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 1998, 133:254-258.
115. Tanaka N, Naoe S, Masuda H, Ueno T Pathological study of sequelae of Kawasaki disease (MCLS) with special reference to the heart and coronary arterial lesions. Acta Pathol Jpn 1986, 36:1513-1527.
116. Furuyama H, Odagawa Y, Katoh C, et al. Assessment of coronary function in children with a history of Kawasaki disease using (15)O-water positron emission tomography. Circulation 2002, 105:2878-2884.
117. Dhillon R, Clarkson P, Donald AE, et al. Endothelial dysfunction late after Kawasaki disease. Circulation 1996, 94:2103-2106.
118. Nakamura Y, Yanagawa H, Harada K, et al. Mortality among persons with a history of Kawasaki disease in Japan: the fifth look. Arch Pediatr Adolesc Med 2002, 156:162-165.
119. Kusakawa S, Tatara K Efficacies and risks of aspirin in the treatment of the Kawasaki disease. Prog Clin Biol Res 1987, 250:401-413.
120. Akagi T, Kato H, Inoue O, Sato N Salicylate treatment in Kawasaki disease: high dose or low dose?. Eur J Pediatr 1991, 150:642-646.
121. Durongpisitkul K, Gururaj VJ, Partin JM, Martin CF The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 1995, 96:1057-1061.
122. Koren G, Silverman E, Sundel R, et al. Decreased protein binding of salicylates in Kawasaki disease. J Pediatr 1991, 118:456-459.
123. Lee JH, Hung HY, Huang FY Kawasaki disease with Reye syndrome: report of one case. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1992, 33:67-71.
124. Furusho K, Kamiya T, Nakano H, et al. High-dose intravenous gamma-globulin for Kawasaki disease. Lancet 1984, 2:1055-1058.
125. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986, 315:341-347.
126. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991, 324:1633-1639.
127. Terai M, Shulman ST Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 1997, 131:888-893.
128. Newburger J Kawasaki disease: Who is at risk?. J Pediatr 2000, 137:149-152.
129. Stockheim A, Innocentin N, Shulman S Kawasaki disease in older children and adolescents. J Pediatr 2000, 137:250-252.
130. Fukunishi M, Kikkawa M, Hamana K, et al. Prediction of non-responsiveness to intravenous high dose gamma-globulin therapy in patients with Kawasaki disease at onset. J Pediatrics 2000, 137:172-176.
131. Han RK, Silverman ED, Newman A, McCrindle BW Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med 2000, 154:694-699.
132. Mori M, Imagawa T, Yasui K, et al. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease. J Pediatr 2000, 137:177-180.
133. Newburger JW, Burns JC, Beiser AS, Loscalzo J Altered lipid profile after Kawasaki syndrome. Circulation 1991, 84:625-631.
134. Tsujimoto H, Takeshita S, Nakatani K, et al. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease. Clin Immunol 2002, 103:161-168.
135. Yi QJ, Li CR, Yang XQ Effect of intravenous immunoglobulin on inhibiting peripheral blood lymphocyte apoptosis in acute Kawasaki disease. Acta Paediatr 2001, 90:623-627.
136. Sherer Y, Levy Y, Langevitz P, et al. Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases. Pharmacology 2001, 62:133-137.
137. Bresee JS, Mast EE, Coleman PJ, et al. Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study. JAMA 1996, 276:1563-1567.
138. Klassen TP, Rowe PC, Gafni A Economic evaluation of intravenous immune globulin therapy for Kawasaki syndrome. J Pediatr 1993, 122:538-542.
139. Marasini M, Pongiglione G, Gazolo D, et al. Late intravenous gamma globulin treatment in infants and children with Kawasaki disease and coronary artery abnormalities. Am J Cardiol 1991, 68:796-797.
140. Tse SM, Silverman ED, McCrindle BW, Yeung RS Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. J Pediatr 2003, 140:450-455.
141. Kato H, Koike S, Yokoyama T Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics 1979, 63:175-179.
142. Nonaka Z, Maekawa K, Okabe T, et al. Randomized controlled study of intravenous prednisolone an gamma globulin treatment in 100 cases with Kawasaki disease. Fifth International Kawasaki Disease Symposium 1994, Elsevier Science, Philadelphia.
143. Shinohara M, Sone K, Tomomasa T, Morikawa A Corticosteroids in the treatment of the acute phase of Kawasaki disease. J Pediatr 1999, 135:465-469.
144. Hashino K, Ishii M, Iemura M, et al. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int 2001, 43:211-217.
145. Sundel RP, Baker AL, Fulton DR, Newburger JW Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. J Pediatr 2003, 142:611-616.
146. Jibiki T, Terai M, Kurosaki T, et al. Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease. Eur J Pediatr 2004, 163:229-233.
147. Furukawa S, Matsubara T, Umezawa Y, et al. Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease. Eur J Pediatr 1994, 153:663-667.
148. Weiss JE, Eberhard BA, Chowdhury D, Gottlieb BS Infliximab as a novel therapy for refractory Kawasaki disease. J Rheumatol 2004, 31:808-810.
149. Mori M, Tomono N, Yokota S Coronary arteritis of Kawasaki disease unresponsive to high-dose intravenous gamma-globulin treatment successfully treated with plasmapheresis. Nihon Rinsho Meneki Gakkai Kaishi 1995, 18:282-288.
150. Wallace CA, French JW, Kahn SJ, Sherry DD Initial intravenous gamma-globulin treatment failure in Kawasaki disease. Pediatrics 2000, 105:E78.
151. Raman V, Kim J, Sharkey A, Chatila T Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy. Pediatr Infect Dis J 2001, 20:635-637.
152. Miyamae T, Nakasima S, Tomono N, et al. Two infants with classic polyarteritis nodosa but not Kawasaki disease. Nihon Rinsho Meneki Gakkai Kaishi 2000, 23:445-453.
153. Williams RV, Wilke VM, Tani LY, Minich LL Does abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?. Pediatrics 2002, 109:E4.
154. Takahashi M, Weinter K: Changes in coronary artery aneurysms following treatment with abciximab. Presented at the Seventh International Kawasaki Disease Symposium. 2001. Hakone, Japan.
155. Shen CT, Wang MK Antioxidants may mitigate the deterioration of coronary arteritis in patients with Kawasaki disease unresponsive to high-dose intravenous gamma-globulin. Pediatr Cardiol 2001, 22:419-422.
156. Zaitsu M, Hamasaki Y, Tashiro K, et al. Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. J Infect Dis 2000, 181:1101-1109.
157. Dajani AS, Taubert KA, Takahashi M, et al. Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1994, 89:916-922.
158. Fulton DR, Newburger JW Long-term cardiac sequelae of Kawasaki disease. Curr Rheumatol Rep 2000, 2:324-329.
159. Cheung YF, Yung TC, Tam SC, et al. Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis. J Am Coll Cardiol 2004, 43:120-124.
160. Dhillon R, Clarkson P, Donald AE, et al. Endothelial dysfunction late after Kawasaki disease. Circulation 1996, 94:2103-2106.
161. McConnell ME, Hannon DW, Steed RD, Gilliland MG Fatal obliterative coronary vasculitis in Kawasaki disease. J Pediatr 1998, 133:259-261.
162. Kuramochi Y, Ohkubo T, Takechi N, Ogawa S Feasibility of percutaneous transluminal coronary angioplasty to patients with Kawasaki disease as an early management strategy. Pediatr Cardiol 2001, 22:183-187.
163. Gotteiner N, Mavroudis CV, Backer CL, et al. Coronary artery bypass grafting for Kawasaki disease. Pediatr Cardiol 2002, 23:62-67.
164. Checchia PA, Pahl E, Shaddy RE, Shulman ST Cardiac transplantation for Kawasaki disease. Pediatrics 1997, 100:695-699.
165. Chang RK Hospitalizations for Kawasaki disease among children in the United States, 1988-1997. Pediatrics 2002, 109:e87.
166. Nakamura Y, Yanagawa H, Ojima T, et al. Cardiac sequelae of Kawasaki disease among recurrent cases. Arch Dis Child 1998, 78:163-165.